Trial Profile
Randomized Crossover study to compare the effects of trelagliptin and omarigliptin on type 2 diabetes mellitus patients who were formerly treated with other DPP-4 inhibitors
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2017
Price :
$35
*
At a glance
- Drugs Omarigliptin (Primary) ; Trelagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Oct 2017 New trial record